Immediate Impact
1 by Nobel laureates 54 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
2025 Standout
Works of Akshanth R. Polepally being referenced
First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors
2021 Nobel
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Akshanth R. Polepally | 409 | 201 | 278 | 37 | 858 | |
| Gerond Lake‐Bakaar | 289 | 225 | 446 | 52 | 1.1k | |
| Prabhu Rajagopalan | 118 | 72 | 96 | 51 | 1.1k | |
| Ting Wang | 432 | 80 | 466 | 36 | 876 | |
| Jong‐Da Lian | 155 | 49 | 219 | 39 | 773 | |
| Sarah Allegra | 213 | 242 | 200 | 56 | 766 | |
| Kelong Han | 77 | 241 | 239 | 41 | 894 | |
| V. Fontana | 100 | 41 | 191 | 31 | 835 | |
| Yoshitane Kosaka | 429 | 46 | 432 | 52 | 962 | |
| Antonio Russo | 182 | 134 | 218 | 63 | 966 | |
| Anther Keung | 42 | 303 | 183 | 24 | 927 |
All Works
Login with ORCID to disown or claim papers
Loading papers...